Discovery of the First-in-Class GSK-3 beta/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease (vol 10, pg 469, 2019)

De Simone Angela; La Pietra Valeria; Betari Nibal; Petragnani Nicola; Conte Mariarosaria; Daniele Simona; Pietrobono Deborah; Martini Claudia; Petralla Sabrina; Casadei Raffaella; Davani Lara; Frabetti Flavia; Russomanno Pasquale; Novellino Ettore; Montanari Serena; Tumiatti Vincenzo; Ballerini Patrizia; Sarno Federica; Nebbioso Angela; Altucci Lucia; Monti Barbara; Andrisano Vincenza; Milelli Andrea

首页> 外文期刊>ACS medicinal chemistry letters >Discovery of the First-in-Class GSK-3 beta/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease (vol 10, pg 469, 2019)

【24h】

Discovery of the First-in-Class GSK-3 beta/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease (vol 10, pg 469, 2019)

机译：发现一流的GSK-3β/ HDAC双抑制剂作为疾病改性剂，用于打击阿尔茨海默病（第10卷，PG 469,2019）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《ACS medicinal chemistry letters》 |2019年第9期|共1页
作者
De Simone Angela; La Pietra Valeria; Betari Nibal; Petragnani Nicola; Conte Mariarosaria; Daniele Simona; Pietrobono Deborah; Martini Claudia; Petralla Sabrina; Casadei Raffaella; Davani Lara; Frabetti Flavia; Russomanno Pasquale; Novellino Ettore; Montanari Serena; Tumiatti Vincenzo; Ballerini Patrizia; Sarno Federica; Nebbioso Angela; Altucci Lucia; Monti Barbara; Andrisano Vincenza; Milelli Andrea;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;化学;
关键词

相似文献

外文文献
中文文献
专利

1. Discovery of the First-in-Class GSK-3 beta/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease (vol 10, pg 469, 2019) [J] . De Simone Angela, La Pietra Valeria, Betari Nibal, ACS medicinal chemistry letters . 2019,第9期

机译：发现一流的GSK-3β/ HDAC双抑制剂作为疾病改性剂，用于打击阿尔茨海默病（第10卷，PG 469,2019）
2. Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3 beta: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease [J] . Kumar Akhil, Srivastava Gaurava, Srivastava Swati, Journal of molecular modeling . 2017,第8期

机译：萘呋喃部分作为潜在的双重抑制剂对抗Bace-1和GSK-3β的研究：分子动力学模拟，结合能量和网络分析，以识别Alzheimer疾病的阶级双重抑制剂
3. Dual BACE-1/GSK-3 beta Inhibitors to Combat Alzheimer's Disease A Focused Review [J] . Rampa Angela, Gobbi Silvia, Di Martino Rita Maria Concetta, Current topics in medicinal chemistry . 2017,第31期

机译：双重BACE-1 / GSK-3β抑制剂，用于打击阿尔茨海默病的重点审查
4. A Bacillus subtilis cell factory for producing scyllo-inositol, a disease-modifying therapeutic agent for Alzheimer's disease [C] . K. Tanaka, S. Tajima, S. Takenaka, International Conference on Environmental, Industrial and Applied Microbiology . 2014

机译：枯草芽孢杆菌细胞厂用于生产Scyllo-inositol，一种用于阿尔茨海默病的疾病改性治疗剂
5. Nitrate Chimeras: A New Class of Disease-Modifying Agents for the Treatment of Alzheimer's Disease. [D] . VandeVrede, Lawren. 2014

机译：硝酸盐嵌合体：治疗阿尔茨海默氏病的新型疾病改良剂。
6. Discovery of the First-in-Class GSK-3β/HDACDual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’sDisease [O] . Angela De Simone, Valeria La Pietra, Nibal Betari, 2019

机译：发现一流的GSK-3β/ HDAC双重抑制剂作为抗病药可对抗阿尔茨海默氏病疾病
7. Correction to “Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease” [O] . Angela De Simone, Valeria La Pietra, Nibal Betari, 2019

机译：纠正“发现一流的GSK-3β/ HDAC双抑制剂作为疾病改性剂来打击阿尔茨海默病的”

Discovery of the First-in-Class GSK-3 beta/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease (vol 10, pg 469, 2019)

著录项

相似文献

相关主题

期刊订阅